Here are five highlights:
1. The company experienced a strong showing in the international market, with good currency performance in the Asia-Pacific region and Europe as well as the Middle East and Africa.
2. NuVasive is positioned to see great growth in the international market. The company is anticipated to see growth of 38 percent in 2016.
3. Zacks also projects NuVasive’s spine market will grow in 2016, fuelled by pipeline updates, acquisition targets and strategic partnerships.
4. The company will, however, face pricing obstacles. NuVasive anticipates a negative 1 percent pricing impact on gross margin.
5. The company will also face strong competition in the market.
More articles on devices:
Motus Global develops wearable tech sleeve for pitchers — 5 things to know
NuVasive to attend 2 investor events — 3 quick notes
Medtronic surpasses Zacks’ estimates of Q4 earnings, 2016 revenues: 6 points
